EGCG has been shown to induce apoptosis by targeting JAK2/STAT3/AKT and Bcr/Abl-mediated p38-MAPK/JNK signalling pathways in chronic myeloid leukaemia (CML) cells [217]. Here, AKT1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.